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1. INTRODUCTION
Basic research into the mechanisms that underpin clinical pathol-
ogy is a vital step in understanding disease mechanisms and in the 
development of therapeutics. Much of this work relies on the use 
of model systems and the use of ex vivo human tissue. Many stud-
ies have highlighted problems in general scientific reporting and 
transparency; it is estimated that 85% of research is wasted by poor 
practice throughout the process [1]. Inadequate reporting prevents 
proper replication and comparison of data, and valuable resources 
that are often difficult and time-consuming to obtain, are squan-
dered. Worryingly, poor reporting in some scenarios can directly 
affect patient care [2,3]. Although this information is primarily 
from clinical trial data, it seems likely that these trends are observed 
across multiple scientific disciplines. In the wider community this 
has led to the development and publication of various report-
ing guidelines such as Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) for systematic reviews [4], 
Animal Research: Reporting of In Vivo Experiments for animal 
studies [5] and Consolidated Standards of Reporting Trials for ran-
domised trials [6]. The Enhancing the QUAlity and Transparency 
of health Research (EQUATOR) network has a searchable library 
for these guidelines and provide toolkits and training to encourage 
the correct and appropriate reporting to maximise output and reli-
ability of studies (https://www.equator-network.org/).
Animal models are extremely important in biomedical research 
for both understanding the pathophysiology of disease processes 
as well as for developing therapeutic interventions. For example 
there are well-established models for arterial diseases including 
hypertension and atherosclerosis [7] However, there can be chal-
lenges with the use of animal models because in many cases they 
fail to recapitulate the complexity of some diseases [8]. There can 
be relatively poor predictive ability associated with translation from 
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A B S T R AC T
Ex vivo human tissue is a valuable research resource. However, if vital methodological information such as anatomical location, 
tissue processing procedures, or donor characteristics are not reported in scientific literature to a high standard, studies utilising 
ex vivo human tissue can be difficult to replicate. Furthermore, data analysis and interpretation based on these studies can be 
challenging. In this systematic review, we focus on the reported use of human aortic tissue in research. The human aorta is a 
complex tissue, with embryological, biochemical and biomechanical variations along its length, which alter with age, and differ 
between genders and ethnicities. The aorta therefore serves as an excellent case study for examining the importance of high 
quality and robust reporting of methodology when utilising human tissue samples, for reliable interpretation and reproducibility. 
In this systematic review, we sought to critically analyse scientific papers published between 1980 and 2017 which utilised human 
aortic tissue to determine whether the methodological information provided would be sufficient for replication, comparison 
with other studies and interpretation. Eight databases (Springerlink, ScienceDirect, PMC, PLoS, JSTOR, Pubmed, Web of 
Science, Scopus) were mined for articles that contained the search term ‘human aortic tissue’ from January 1980 to August 2017. 
Following review, 143 full-text articles were selected, data extracted, tabulated and analysed. The review highlighted several areas 
where reporting of human aortic tissue use was insufficient for replication and thorough data interpretation. The use of control 
tissue was often poorly explained and in many cases, omitted completely. Sample size was largely difficult to calculate and 30% 
of studies did not provide this information. Age/gender information was absent in 30% of studies. Tissue storage and handling 
information was present in 78%, and 75% of studies gave information about statistical analyses but few gave enough information 
for replication. Overall the quality of reporting in many studies was deemed to be of a low standard for replication and reliable 
interpretation of the reported findings. Here we propose five simple recommendations for the reporting of human tissue with the 
primary aim of improving reproducibility and transparency in the sector, avoiding bias and maximising output.
© 2019 Association for Research into Arterial Structure and Physiology. Publishing services by Atlantis Press International B.V. 
This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).
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animal studies to human trials, resulting in a high drop-out rate 
at failed clinical trials [9,10]. Human tissue is therefore an appeal-
ing alternative to animal models; however, obtaining appropriate 
human samples and suitable control tissues is challenging [11].
Age, race and gender are factors that significantly alter human bio-
chemistry and physiology [12,13]. It is logical therefore that, where 
possible, samples compared across different patient groups should 
be age, ethnicity and gender matched to minimise the impact of 
these variables on any study in question. Furthermore, different 
sample handling and processing techniques required for exper-
imentation can affect their properties. Collectively, if these fac-
tors are not taken into consideration during analysis it can result 
in erroneous interpretation of results. The difficulty of obtaining 
appropriate control tissue for human tissue studies make the sce-
nario of the perfect age/gender matched control tissue from dis-
ease-free patients that have been handled/treated identically a near 
impossibility [11]. Within the EQUATOR library, there is a single 
guideline document identified from the search term ‘human tissue’ 
entitled ‘Biospecimen reporting for improved study quality’ or 
BRISQ [14]. BRISQ highlights some of these issues, in particular 
those relating to handling and storage of human samples and puts 
forward very comprehensive guidelines for the reporting of these 
parameters. However, BRISQ does not cover some of the other key 
areas that are critical for interpretation and replication of studies 
involving human tissue. For example, sample size, use of control 
tissue and data analysis are not specifically covered in the BRISQ 
guidelines. The present review aims to appraise a subset of research 
articles which use human aortic tissue in basic research as an exem-
plar for the wider discussion on human tissue use.
The human aorta is an embryologically complex tissue. Formation 
of the heart occurs early in embryonic development, a pool of car-
diac precursor cells fuse in the midline and form a beating linear 
tube, as it elongates through the proliferation of precursor cells it 
loops to form the four-chambered heart with a single outflow tract 
[15]. This single outflow tract is connected to the aortic sac from 
which the pharyngeal arches derive, connecting the heart to the 
dorsal aortae (Figure 1, left). There are five pairs of arches that are 
subsequently remodelled. The first and second arch pairs involute; 
the third arch pair transforms into the common carotid and the 
proximal internal carotid arteries. The left fourth arch becomes 
Figure 1 | Embryonic development of the aorta highlighting the different 
embryological origins of the aortic anatomy.
part of the aortic arch, whilst the right fourth arch forms part of the 
right subclavian artery. Proximal portions of the sixth arch arteries 
form the right and left pulmonary arteries respectively. The distal 
portion of the right sixth arch involutes, whereas the distal part of 
the left sixth arch forms the ductus arteriosus. The dorsal aortae 
reorganise; the right branch into the right subclavian and the left 
branch becomes the aortic arch and descending aorta [15–17]. As 
demonstrated in Figure 1, the fully formed aorta comprises tissue 
derived from five distinct cell populations.
In addition to different embryological origins, regions of the aorta 
have different mechanical [18,19] and biological properties [20,21] 
that change with age [19] and gender [22]. For these reasons, it is 
critical that accurate reporting is in place to ensure correct inter-
pretation and understanding of the data presented. Although the 
comments herein are related to the aorta specifically, the issues 
raised are relevant to all human tissue research.
We hypothesised that reporting and methodology surrounding 
the use of human aortic tissue would prove insufficient for thor-
ough replication and comparison across studies, and that the use of 
appropriate control samples would be lacking. We aimed to high-
light areas in experimental design and reporting of information 
that require improvement and put forward simple recommenda-
tions to permit comparison across studies and enhance translation 
from bench to bedside.
2. MATERIALS AND METHODS
2.1. Search Strategy and Article Selection
A schematic overview of the review protocol is given in Figure 2. To 
identify published articles that involved the study of human aortic 
tissue, we searched eight databases (Springerlink, ScienceDirect, 
PMC, PLoS, JSTOR, Pubmed, Web of Science, Scopus) for articles 
Figure 2 | Schematic overview of the systematic article selection. Article 
numbers at each stage are presented in square parentheses.
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that contained the search term ‘human aortic tissue’. This search 
term was designed to identify articles that used human aortic 
tissue in research (Table S1). The review aimed to take a snapshot 
of research pertaining to human aortic tissue samples and assess 
the reporting, rather than to exhaustively assess all work on human 
aortae. As such we only used the single search term. The inclusion 
and exclusion criteria were agreed by all authors prior to review 
and are detailed in Table 1.
The initial review process, search result consolidation, duplication 
removal and abstract screening was managed using Covidence 
 software (Melbourne, Australia). Abstract screening and subsequent 
full-text review and data mining was performed by two reviewers, and 
differences of opinion were resolved through discussion. A further 
thirty papers were randomly selected for assessment by a third 
reviewer.
2.2. Data Evaluation
The basic characteristics of the selected articles such as author 
information, publication year and journal classification according 
to Journal Citation Reports (JCR), were tabulated. We also catego-
rised the techniques used into biomechanical, biochemical or imag-
ing and combinations thereof. Where possible the mean number of 
patient samples used per group/per experiment were recorded. The 
inclusion of age/gender information, tissue handling/storage infor-
mation and statistical methods were also recorded and tabulated 
(Table S1).
A key aim of this review was to assess the quality of experimental 
controls. During the review of each article, the type of experimental 
control was recorded and then subsequently divided into four cat-
egories; non-diseased human tissue, comparison study, no controls 
used and other. Details of these categories can be found in Table 2.
3. RESULTS
Primary database searches yielded 623 articles for initial abstract 
review. Following abstract screening, 210 papers were selected for 
full paper review and a total of 143 full-text articles were fully ana-
lysed and included in the review (Figure 2). The primary reason 
for exclusion after abstract screening was the lack of human aortic 
tissue use (e.g. computational modelling of the aorta where no 
experimental work on tissue samples had been conducted, or 
where animal tissue was utilised and compared to human tissue 
data from other studies).
Table 1 | Inclusion/Exclusion criteria
Inclusion
• Papers published in English
• Between 1980-08/2017
• Must have associated full text
• Must perform experiments on human aortic tissue
• Any histological layer of the aorta
• Any regional location e.g. ascending/descending
• Original research
Exclusion
• Papers that only investigate the aortic valve
Table 2 | Control categories
1. Human non-disease tissue
Same human
• Same site (e.g. disease free region)
• Different site (e.g. infrarenal aorta compared to ascending)
Different human
• Same site (e.g. cadaveric ascending aorta compared with diseased 
ascending aorta)
• Different site (e.g. abdominal aorta from kidney transplant donor 
acting as controls for ascending aorta)
2. Comparison study
Effect of treatment study
Disease comparison
Age comparison
3. No controls used
No controls used (e.g. single disease study with no control)
Information unclear/insufficient detail
Pilot study/method development
No controls – not needed (e.g. only healthy tissue used)
Cell or protein isolation studies
4. Other
Animal tissue
3.1. Characterisation of Subject Articles
From our study it is apparent that there is an overall upward trend 
in the number of papers being published that use aortic human 
tissue, from 1980 to 2017 (Figure 3A). The articles came from a 
wide range of journals, spanning across 25 different classifications. 
Most of the papers came from the following four JCR classifica-
tions; surgery, peripheral vascular disease, engineering-biomedical 
and pathology (Figure 3B). Assessment of the research discipline 
as biomechanical, biochemical or imaging revealed that 62% of the 
articles fell into a single discipline, 38% crossed at least two disci-
plines and overall 75% of the articles included some biochemistry 
(Figure 3C).
3.2. Tissue Source and Control Tissue
The tissue samples used in the studies reviewed were obtained from 
three sources; during surgery, at autopsy or from transplant organs 
(heart/kidneys). Most tissues were from surgery or autopsy or a 
combination thereof (31%, 30% and 22% respectively) (Figure 4A).
A key aim of this review was to explore the use of different controls 
in experiments involving human aortic tissue. To simplify the dis-
cussion, the use of controls within the review articles was divided 
into four categories; healthy human aortic tissue, comparative stud-
ies, no controls used and other. The details of each grouping can be 
found in Table 2. Within this cohort, 98 studies used non-diseased 
human tissue as a control, 10 were comparison studies between dis-
ease groups and 28 studies fell under the category of ‘no controls’ 
(Figure 4B).
Whilst the number of studies using non-diseased human tissue is 
high, these divide into several sub-categories with overlap in some 
instances. Most of the studies in this category compared diseased 
tissue with non-diseased tissue from autopsy or transplant organs. 
This option represents a good model with regards to comparing 
healthy and diseased tissue; however, a major drawback can be the 
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Figure 4 | Tissue source and control tissue information. Breakdown of 
tissue source (A) and the control categories (B).
Figure 3 | Overview of the paper characteristics included in the study. The number of studies published by year (A), journal classification (Journal 
Citation Reports) (B) and the breakdown of primary experimental techniques used in the articles as a Venn diagram (C).
differences in tissue handling. In most of the studies where autopsy 
tissue was used, the time of tissue collection post-mortem was 
either not stated or was hugely varied. It has long been established 
that DNA remains relatively stable during the post-mortem inter-
val; however, RNA and proteins level are much more labile [23–25]. 
Thus, comparison of post mortem tissue with tissue collected from 
patients during surgery must be approached with caution.
In some of the studies the authors compared diseased tissue with 
tissue collected from a different non-diseased site during surgery 
such as punch biopsies from coronary artery bypass or strips of 
aorta taken during valve replacement surgery. Although the aorta 
in these instances maybe largely normal, these patients have clin-
ically significant disease and thus are not likely to truly represent 
healthy tissue. Similarly, many studies took a single cohort of 
patients e.g. all autopsy cases and then used histology to classify 
the patients into groups, with one of the groups representing 
disease-free or ‘normal control’. This has benefits with regards to 
age/gender matching and equal group size; however, it again raises 
the question of whether the tissue can truly be considered a ‘normal’ 
sample if the donor has some level of cardiovascular disease.
Furthermore, it was noted during the analysis that in some cases 
‘comparative’ tissues were collected from different sites e.g. tho-
racic aorta with infrarenal aorta. Different regions of the aorta have 
different embryological origins [16], cellular and matrix organisa-
tion [26] as highlighted above. It is important to understand these 
differences and to take them into consideration when compar-
ing across different regions; to ensure that differences and study 
findings being reported are a true reflection of a disease process, 
and not anatomical location differences. These caveats may not be 
relevant to some studies; however, clear reporting of all relevant 
details including tissue location and detailed storage information 
will allow the community to appraise studies with all the relevant 
information to make appropriate conclusions from these studies.
The ‘no control’ group was particularly broad comprising pilot 
studies or cell isolation studies of healthy individuals, and in other 
instances where the investigators did not deem control tissue to be 
necessary. However, despite this variation most of the studies within 
the ‘no control’ group (Group 3) did not include any controls, or 
the information was not available or insufficient to appraise. There 
were only seven studies in the final group (Other).
3.3. Patient Numbers
Another key aim of this study was to investigate the sample size. Due 
to the difficulty in obtaining human tissue, the number of patient 
samples used in human studies is relatively low compared to animal 
studies and can often be underpowered. Publications reviewed here 
are no exception; where possible the number of patients per group 
per experiment was extracted from the articles and represented in 
Figure 5. The mean number of patients per group per experiment 




 Y.-H. Chim et al. / Artery Research 25(1-2) 3–10 7
Figure 5 | Analysis of patient numbers used in studies shown as box 
plot. The plot shows the mean number of patients used per experiment 
per group, where it was possible to determine this information. Variable 
distribution is shown as blue box containing the interquartile ratio (first 
and third quantiles) with the median (central line) and mean (dashed 
line) shown, whiskers represent the 5–95% range respectively.
justified because the study’s aim was either method development or a 
proof of concept; further investigations must contextualise the find-
ings presented based on sample size, and to avoid any inference to the 
larger population until further independent validation is obtained.
Another important point to consider is the correct standardisation 
of sample size reporting. A large percentage of manuscripts tend to 
report sample size as a cumulative figure for all of the samples used 
in the different experiments presented in the manuscript. While 
technically correct, this might mislead the readers as it implies that 
the power of the study is much larger than it is. A more correct 
approach would be to report the sample size used per test, as this 
accurately informs about their power. In many publications, the 
number of samples varies for different experiments/tests. However, 
the rationale for this is often lacking. This can point towards simple 
limitations in experimental design or budget but can also point 
towards biased presentation of results by selecting the specific sam-
ples that best fit the hypothesis.
In cases where it was possible to determine n numbers, in many 
cases, the information had to be calculated or determined from 
graphs, or from information presented within figure legends, and 
this information was not readily accessible within the methods sec-
tion. The average reader is not likely to read in this much detail and 
thus there is again scope for misinterpretation.
Strikingly, it was not possible to extract sample size information 
from 30% of papers. The primary reason for this was unclear divi-
sion of the number of samples from patients into different experi-
mental groups. For example, a study may have collected 50 samples 
from 12 patients and then re-categorised them based on histologi-
cal findings into four groups. This made it difficult to ascertain how 
many patients contributed to the samples in each group. It could for 
example be possible that the samples for an entire group came from 
a single patient.
It was also interesting to note that in many cases the number 
of patients in the study group was significantly higher than the 
corresponding control group. It is also noted that n number was 
particularly difficult to determine for imaging studies where rep-
resentative images are presented, but no indication provided as to 
how many samples or patients the reported result was observed in.
3.4. General Reporting Issues
In addition to the parameters stated above, there are several other 
key factors that need to be reported to put the research into the 
appropriate context and provide information that is important for 
reproducibility including: patient metadata storage and handling 
information and details of statistical analyses.
In the papers assessed in this review, 30% of the studies presented 
no age or gender information. As alluded to earlier, age and gender 
information is key to the interpretation of data and if not taken into 
account can generate bias. Many studies detail changes in the aorta 
associated with age and the corresponding alterations in geometry 
[22], biochemical and mechanical properties [18]. Many of these 
also differ between genders. There is a gender-related discordance 
in the incidence and outcomes of aortic aneurysm [27] and dis-
section [28], which is yet to be fully explained. However, there are 
suggestions that hormonal differences play a role and that there 
may be differences in elastin and elastolytic enzymes between the 
sexes [29].
Almost all the studies failed to detail other potential confounding 
factors such as Body Mass Index (BMI), history of hypertension, 
statin use, diabetes etc. Ethnicity data were noticeably absent from 
all but a handful of studies. Epidemiology data has identified dif-
ferences in the prevalence of aortic disease between ethnicities. For 
example the incidence of abdominal aortic aneurysm in men in the 
Asian population is reportedly 10-fold lower than that of Caucasian 
men [30]; African-Americans are at significantly lower risk of devel-
oping severe aortic stenosis than Caucasians [31]. Physiological 
differences have also been reported such as such as thicker aortic 
wall [32] and higher pulse wave velocity measurements [33,34] in 
African-Americans when compared to Caucasians. Although these 
differences are smaller than the contributions made by age and 
gender [32], they are nonetheless factors to consider in analysis, 
particularly given the marked difference in prevalence between 
ethnic groups.
Storage and handling information was provided in 78% of the stud-
ies reviewed here. However, in most of the studies, the information 
was insufficient for replication of the procedure. It is well estab-
lished that storage and handling of tissues can affect their biological 
properties. Practically, it is highly likely that tissues will be stored 
or processed prior to analysis; however, it is critical that these pro-
cesses and procedures are consistent within a study as far as possi-
ble and well reported. There is evidence that freezing aorta samples 
and storage prior to analysis does not affect the biomechanical 
properties of the aorta [35]. Nevertheless, subtle differences in pro-
tocol have been shown to alter properties. For example, samples 
stored at different temperatures exhibited altered biomechanical 
properties [36–38].
Regarding statistical tests, 75% provided information about all or 
some of analyses performed. However, a largely shared caveat was 
the lack of evidence to support the choice of statistical tests (such 
as assumptions of normality or homoscedasticity) that classically 
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defaults to Student’s t-tests and ANOVA with no consideration for 
more suited non-parametric alternatives when the general hypoth-
eses could not be met. Furthermore, several graphical representa-
tions lack uncertainty measures (e.g. error bars or standard deviation 
values), which are paramount to assess the validity of the data pre-
sented. Most publications reviewed in this work do not provide the 
data used for the analysis nor full disclosure of patient/animal meta-
data, which makes it impossible to reproduce the analysis or test 
further hypotheses. It is also noteworthy that several methodological 
publications (e.g. optical imaging techniques) do not provide evi-
dence on the internal validation of their method to account for bias 
in quantification/detection within technical replicates.
3.5. Limitations of the Study
This review represents a snapshot in time of research papers per-
taining to the study of human aortic tissue. Although the search 
term was broad some papers may have inadvertently been omitted 
if they did not include the exact term. We have used human aortic 
tissue as an exemplar tissue, but we strongly believe that many of 
the pitfalls highlighted here are relevant to research in other human 
tissue; however, we also recognise that this focussed review does 
not provide that evidence.
In order to probe some of these issues it was necessary to classify 
studies into categories. This categorisation is by nature subjective; 
we have tried to limit this by obtaining a consensus between at least 
two authors for all classifications made.
4. CONCLUSION
In general, the reporting of all key information that is required 
to replicate a study and compare data across different studies was 
poor. In very few cases the information was easily obtained; how-
ever, in the vast majority the required information was presented 
in a disjointed manner, for example, spread across a number of 
sections and within the supplementary information.
We acknowledge that it is often beyond the control of the research 
group to obtain perfectly matched comparison groups in a study 
(e.g. equal numbers in each sub-group). However, this should 
be recognised in a limitations section within the article so that 
the reader is fully aware and can consider these limitations 
when assessing the relevance of the data presented and design of 
future studies.
4.1. Recommendations
The aim of this review is to appraise a subset of research articles 
which use human aortic tissue in basic research as an exemplar for 
the wider discussion on human tissue use. This review has high-
lighted several common pitfalls that we feel are not addressed 
within the guidelines currently available within the EQUATOR 
library. In order to improve the reproducibility and transparency 
for the studies involving human tissues, there is a definite need 
for guidance that can be adopted by the broader scientific com-
munity and embraced by the peer-review system. Below (Table 3), 
we outline some basic and achievable points for reporting studies 
involving the use of human aortic tissue specifically but have broad 
relevance to all studies involving human tissue.
4.1.1.  Clearly describe the cohort(s) used  
in the methods
This should include detail about tissue source (cadaveric/transplant 
etc) and sample size, including the number of pieces per patient, 
for each experiment. If division of tissue samples is complex, we 
suggest including a table outlining each experiment and the corre-
sponding patients involved. If samples are excluded explicitly, state 
the reason for exclusion.
4.1.2.  State the site of tissue collection  
and give full details of storage and 
handling information
This is particularly important for aortic tissue; Figure 6 details pos-
sible division of the aorta that takes account of some of the regional 
differences highlighted in Figure 1. Most of the studies discuss 
aortic tissue as either, root and ascending, arch or descending 
(Figure 6A). Whilst better than no division at all, this description 
is limited and given the considerable variations in properties along 
the aortic length, a more detailed description would be advanta-
geous. Taking account of the embryological and haemodynamic 
differences, we propose division of the aorta into a minimum of 
10 sections (Figure 6B). There is of course scope for further divi-
sion particularly of the descending thoracic aorta to correspond to 
intercostal branches. However, this limited improvement would be 
significantly better than existing reporting.
Table 3 | Recommendations
1. Clearly describe the cohort(s) used in the methods.
2. State the site of tissue collection.
3. Provide patient demographic data.
4. Make all raw and processed data available.
5. Describe and discuss the limitations of the study.
Figure 6 | Possible division of the aorta into reporting sections. Division 
of the aorta into three sections, most commonly observed in the studies 
reviewed herein (A). Proposed division incorporating embryological 
and haemodynamic differences which could affect mechanical and 
biochemical properties (B).
A B
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4.1.3.  Detail the patient demographic  
data in a table including age/ 
gender/race/BMI/other clinical  
confounding factors
Metadata is key to the wider interpretation of data. As we acknowl-
edge earlier, it is incredibly difficult to obtain perfectly matched 
disease and control samples especially in the study of cardiovascu-
lar diseases where often the only source of ‘healthy tissue’ is cadav-
eric. Accordingly, it is particularly important to outline the patient 
metadata to enable the reader to interrogate potential limitations 
in matching and the implications for the findings. As well as giving 
the opportunity to draw further hypotheses to test within the dif-
ferent demographics presented.
4.1.4.  Make all raw and processed  
data available
The benefit of this is twofold. First, it increases the amount of data 
available for the community to use, making the most of this scarce 
resource and encourages collaboration. Second, it promotes trans-
parency and enables thorough replication.
4.1.5.  Describe and discuss the limitations 
of the study
When working with human samples there are unavoidable limita-
tions that all researchers must face. However, to minimise unwanted 
bias and patient misclassification it is necessary to provide a proper 
description and discussion of limitations to help less-specialist 
readers interpret data correctly and highlight additional areas for 
future research.
Many of these points are universally applicable to human tissue 
studies in general. Accordingly, we have registered our intent with 
the EQUATOR network to develop simple reporting guidelines for 
the use of human tissue in research.
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